GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gland Pharma has published newspaper advertisements informing shareholders about the audited financial results for FY26 (year ended March 31, 2026). The Board of Directors approved these standalone and consolidated results on May 15, 2026. The results, along with audit reports from Deloitte Haskins & Sells, were published in both English and Telugu newspapers. This filing is a mandatory compliance requirement under SEBI Listing Regulations. The actual financial figures are not included in this notice but are available on the company's investor relations website and stock exchange portals.
This is a routine regulatory filing with no immediate impact on the stock. The actual financial performance numbers would have been disclosed in the detailed results filing. Shareholders should refer to the full results filing for actual revenue, profit, and other key metrics.